# OWO · Drug-Eluting Sinus Stent

_ ·  · Class 3_

**Canonical URL:** https://fda-staging.innolitics.com/productcode/OWO

## Overview

- **Product Code:** OWO
- **Device Name:** Drug-Eluting Sinus Stent
- **Regulation:** 21 CFR N/A
- **Device Class:** 3
- **Review Panel:** [](/submissions/)
- **Implant:** yes

## Identification

Mechanically maintain patency following ethmoid sinus surgery. By also eluting drugs, reduce the need for post-operative intervention such as surgical adhesion lysis and/or use of oral steroids.

## Recent Cleared Devices (3 of 3)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [P100044S023](/device/P100044S023.md) | PROPEL CONTOUR SINUS IMPLANT | Intersect Ent. | Feb 23, 2017 | APPR |
| [P100044S018](/device/P100044S018.md) | PROPEL MINI SINUS IMPLANT | Intersect Ent. | Mar 23, 2016 | APPR |
| [P100044](/device/P100044.md) | PROPEL | Intersect Ent. | Aug 11, 2011 | APPR |

## Top Applicants

- Intersect Ent. — 3 clearances

---

**Source:** [https://fda-staging.innolitics.com/productcode/OWO](https://fda-staging.innolitics.com/productcode/OWO)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com